Gain Therapeutics (GANX) Receivables - Net (2020 - 2021)

Gain Therapeutics has reported Receivables - Net for 2 years, with the latest figure at $24713.0 in Q3 2021.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $24713.0 in Q3 2021; TTM through Sep 2021 was $24713.0, a N/A change from a year earlier, with the FY2020 full-year figure at $8548.0, changed N/A from the prior year.
• Receivables - Net was $24713.0 for Q3 2021 at Gain Therapeutics, down from $353166.0 in the prior quarter.
• The five-year high for Receivables - Net was $353166.0 in Q2 2021, with the low at $4486.0 in Q1 2021.